Background. Newer oral anticoagulants (NOACs) are being utilized increasingly for the
treatment of venous thromboembolism (VTE). NOAC use is the standard of care for stroke …

Abstract Background and Aims Direct oral anticoagulants (DOAC) are important new
anticoagulant therapies that are not well studied in patients with chronic liver disease. The …

For more than 60 years, warfarin was the only oral anticoagulation agent available for use in
the United States. In many recent clinical trials, several direct oral anticoagulants (DOAC s) …

Atrial fibrillation (AF) is the most common arrhythmia worldwide and is associated with
significant morbidity and mortality. A number of risk factors have been associated with AF …

Ethnopharmacological relevance Chinese materia medica (CMM) has been widely used as
an approach of ethnomedicine worldwide. Recently, there are growing concerns related to …

Objective Non-vitamin K antagonist oral anticoagulants have shown similar efficacy and
lower bleeding rates than vitamin K antagonists for venous thromboembolism. However, this …

Physiological changes with age may alter absorption, distribution, metabolism, and
excretion of drugs in the elderly population. Reduced elimination and prolonged half-life are …

Geriatric patients with non-valvular atrial fibrillation (AF) are increasingly being treated with
novel oral anticoagulants (NOAC) to prevent ischemic stroke. This article highlights the …

The new oral anticoagulants (NOACs) have radically changed the approach to the treatment
and prevention of thromboembolic pulmonary embolism. The authors of this position paper …

A morbidly obese patient with history of deep vein thrombosis and pulmonary embolism was
diagnosed with an acute left upper extremity deep vein thrombosis and started on …